Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Barbara Ryan currently holds 5,724 shares of MiNK Therapeutics, Inc. (INKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barbara Ryan has been a net buyer of INKT stock. They have purchased $38.7K and sold $5.4K worth of shares.
Barbara Ryan's most recent insider trade was on Mar 13, 2026, when they purchased 8 shares at $31.09 per share.
Barbara Ryan serves as Executive at MiNK Therapeutics, Inc. (INKT). They have executed 21 insider transactions totaling $44.1K over their tenure at the company.
Barbara Ryan holds the position of Executive at MiNK Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Barbara Ryan has shown a buying trading pattern, with $38.7K in total purchases and $5.4K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Barbara Ryan was on Sep 15, 2022, when they purchased $35.5K worth of INKT shares. This transaction involved 13,550 shares at $2.62 per share.
Barbara Ryan currently owns 5,724 shares of MiNK Therapeutics, Inc. (INKT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Barbara Ryan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Barbara Ryan has 21 Form 4 filings on record as an insider at MiNK Therapeutics, Inc..
Set alerts for Barbara Ryan and 40,000+ other insiders.